- Home
- ONCO vs BNBX Comparison
ONCO vs BNBX Comparison
Compare ONCO & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- BNBX
- Stock Information
- Founded
- ONCO 2018
- BNBX 1983
- Country
- ONCO United States
- BNBX United States
- Employees
- ONCO N/A
- BNBX N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- BNBX Other Consumer Services
- Sector
- ONCO Health Care
- BNBX Consumer Discretionary
- Exchange
- ONCO Nasdaq
- BNBX Nasdaq
- Market Cap
- ONCO 4.7M
- BNBX 5.5M
- IPO Year
- ONCO 2022
- BNBX N/A
- Fundamental
- Price
- ONCO $3.15
- BNBX $3.40
- Analyst Decision
- ONCO
- BNBX
- Analyst Count
- ONCO 0
- BNBX 0
- Target Price
- ONCO N/A
- BNBX N/A
- AVG Volume (30 Days)
- ONCO 70.5K
- BNBX 3.0M
- Earning Date
- ONCO 12-09-2025
- BNBX 12-16-2025
- Dividend Yield
- ONCO N/A
- BNBX N/A
- EPS Growth
- ONCO N/A
- BNBX N/A
- EPS
- ONCO N/A
- BNBX 211.51
- Revenue
- ONCO $1,326,959.00
- BNBX $3,743,063.00
- Revenue This Year
- ONCO N/A
- BNBX $57.08
- Revenue Next Year
- ONCO N/A
- BNBX $40.00
- P/E Ratio
- ONCO N/A
- BNBX $0.02
- Revenue Growth
- ONCO N/A
- BNBX 55.60
- 52 Week Low
- ONCO $2.45
- BNBX $2.13
- 52 Week High
- ONCO $251.60
- BNBX $190.80
- Technical
- Relative Strength Index (RSI)
- ONCO 43.15
- BNBX N/A
- Support Level
- ONCO $3.48
- BNBX N/A
- Resistance Level
- ONCO $3.99
- BNBX N/A
- Average True Range (ATR)
- ONCO 0.22
- BNBX 0.00
- MACD
- ONCO -0.04
- BNBX 0.00
- Stochastic Oscillator
- ONCO 21.50
- BNBX 0.00
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About BNBX Applied DNA Sciences Inc. Common Stock
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.